Kurman RJ,Shih IM.The origin and pathogenesis of epithelial ovarian cancer:a proposed unifying theory[J].Am J Surg Pathol,2010,34(3):433-443.
[4]
Steffensen KD,Alvero AB,Yang Y,et al.Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer[J].J Oncol,2011,2011:620523.
Oktem G,Sanci M,Bilir A,et al.Cancer stem cell and embryonic development associated molecules contribute to prognostic significance in ovarian cancer[J].Int J Gynecol Cancer,2012,22(1):23-29.
[7]
Liu M,Mor G,Cheng H,et al.High frequency of putative ovarian cancer stem cells with CD44/CKl9coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer[J].Reprod Sci,2013,20(5):605-615.
ShiJ,Zhou Z,Di W,et al.Conelation of CD44v6expression with ovarian cancer progression and recurrenee[J].BMC Cancer,2013,13:182.
[13]
Ikenaga N,Ohuchida K,Mizumoto K,et al.Characterization of CD24expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas[J].Hum Pathol,2010,41(10):1 466-1 474.
[14]
Lim SC,Oh SH.The role of CD24in various human epithelial neoplasias[J].Pathol Res Pract,2005,201(7):479-486.
